Operating Income (Loss) in USD of FIBROGEN INC from 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Fibrogen Inc quarterly/annual Operating Income (Loss) history and change rate from 2013 to Q3 2025.
  • Fibrogen Inc Operating Income (Loss) for the quarter ending September 30, 2025 was -$5.41M, a 88.7% increase year-over-year.
  • Fibrogen Inc Operating Income (Loss) for the twelve months ending September 30, 2025 was -$39.5M, a 83.4% increase year-over-year.
  • Fibrogen Inc annual Operating Income (Loss) for 2024 was -$150M, a 53.4% increase from 2023.
  • Fibrogen Inc annual Operating Income (Loss) for 2023 was -$323M, a 7.21% decline from 2022.
  • Fibrogen Inc annual Operating Income (Loss) for 2022 was -$301M, a 4.33% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

FIBROGEN INC Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$39.5M -$5.41M +$42.3M +88.7% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q2 2025 -$81.8M -$12.1M +$34.4M +74% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-11
Q1 2025 -$116M -$14.9M +$34.3M +69.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q4 2024 -$150M -$7.13M +$88M +92.5% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-17
Q3 2024 -$238M -$47.7M +$15.8M +24.9% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q2 2024 -$254M -$46.4M +$41.6M +47.3% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-11
Q1 2024 -$296M -$49.2M +$26.9M +35.4% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q4 2023 -$323M -$95.1M -$28.9M -43.8% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-17
Q3 2023 -$294M -$63.5M +$30.2M +32.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$324M -$88M -$9.82M -12.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$314M -$76.1M -$13.1M -20.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 -$301M -$66.2M +$69.1M +51.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 -$370M -$93.7M -$145M -284% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$225M -$78.2M +$55.6M +41.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$281M -$63M +$7.43M +10.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$289M -$135M -$77.2M -133% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 -$211M $51M +$18.6M +57.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$230M -$134M -$48.7M -57.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$181M -$70.4M +$10.6M +13.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$192M -$58M +$42.4M +42.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 -$234M $32.3M +$85.2M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$320M -$85.1M -$198M -175% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$122M -$81.1M -$32.2M -66% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$89.3M -$100M -$120M -604% Oct 1, 2019 Dec 31, 2019 10-K/A 2022-03-04
Q3 2019 $31M -$52.9M -$10.1M -23.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $41.1M $113M +$136M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$94.9M -$48.8M -$8.24M -20.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$86.7M $19.9M +$55.5M Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$142M -$42.8M -$20M -88.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$122M -$23.2M +$6.9M +22.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$129M -$40.6M -$11.8M -40.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$117M -$35.6M -$7.92M -28.6% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 -$109M -$22.7M -$637K -2.88% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$109M -$30.1M -$56.7M -214% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$52.1M -$28.8M -$2.04M -7.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$50M -$27.7M +$20.8M +42.9% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 -$70.8M -$22.1M +$21.7M +49.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$92.5M $26.5M -$32.8M -55.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$59.7M -$26.8M +$17.9M +40.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$77.6M -$48.4M -$473K -0.99% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 -$77.2M -$43.8M -$6.68M -18% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$70.5M $59.3M +$10.1M +20.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$80.6M -$44.7M -$30.5M -215% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$50.1M -$48M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 -$37.1M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $49.2M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$14.2M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12

FIBROGEN INC Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$150M +$172M +53.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-17
2023 -$323M -$21.7M -7.21% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-17
2022 -$301M -$12.5M -4.33% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 -$289M -$96.7M -50.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 -$192M -$103M -115% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 -$89.3M -$2.62M -3.02% Jan 1, 2019 Dec 31, 2019 10-K/A 2022-03-04
2018 -$86.7M +$30.6M +26.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$117M -$67.2M -134% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 -$50M +$27.6M +35.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 -$77.6M -$27.5M -54.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 -$50.1M -$42.2M -530% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
2013 -$7.95M Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.